ARTICLE SUMMARY:
Real-world data is embraced in China with an interesting pilot program in Hainan Province and new draft guidelines from the National Medical Products Administration.
The promise of real-world data to support a medical device regulatory strategy is attracting serious attention from regulators around the globe, and China is no exception. The country’s national and regional policymakers have recently advanced new policies to accelerate the practice.
